Add to ORKGA survey is presented of the current chemotherapy of bronchial carcinoma, excluding small cell carcinoma. Multiple drug treatment has made considerable progress in recent years and further prospective clinical trials, using new investigational drugs and protocols, are warranted. Current strategies and associated supportive treatments are discussed.SCOPUS: NotDefined.jinfo:eu-repo/semantics/publishe
According to the number of deaths lung cancer is the leading cancer type, and non-small cell lung ca...
Copyright © 2013 Xiaofei Wang, Baohui Han. This is an open access article distributed under the Crea...
Surgery, chemotherapy, radiotherapy and "biological" treatment are differently used in the treatment...
Multiple-drug chemotherapy has markedly improved the survival of patients with non oat-cell bronchia...
Chemotherapy in non-small cell bronchial carcinoma Each year about 40 000 people in the United King-...
In approximately 80% of the patients with limited disease, the administration of treatment, either c...
MODEST RESULTS TILL NOW: Despite progress in the treatment of bronchial cancer (BC) over the last 20...
Introduction:Bronchioloalveolar carcinoma (BAC) is a subtype of adenocarcinoma of the lung with uniq...
The majority of patients with non-small cell lung cancer (NSCLC) present with advanced stage at diag...
OBJECTIVE: This study aims to assess the international practice of management of bronchial carcinoi...
Objective: Yo evaluate methods of diagnosis and treatment, and the long term survival of patients tr...
International audienceBACKGROUND: Patients with a previous history of cancer of the upper respirator...
肺癌在全球范围内呈上升状态,仅2005年在美国新发病者就有172000例之多.非小细胞肺癌(non-small cell lung cancer,NSCLC)占肺癌的80.0%以上.其中细支气管肺泡癌...
Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the pati...
Lung cancer is the most devastating, yet preventable, cause of premature cancer mortality and morbid...
According to the number of deaths lung cancer is the leading cancer type, and non-small cell lung ca...
Copyright © 2013 Xiaofei Wang, Baohui Han. This is an open access article distributed under the Crea...
Surgery, chemotherapy, radiotherapy and "biological" treatment are differently used in the treatment...
Multiple-drug chemotherapy has markedly improved the survival of patients with non oat-cell bronchia...
Chemotherapy in non-small cell bronchial carcinoma Each year about 40 000 people in the United King-...
In approximately 80% of the patients with limited disease, the administration of treatment, either c...
MODEST RESULTS TILL NOW: Despite progress in the treatment of bronchial cancer (BC) over the last 20...
Introduction:Bronchioloalveolar carcinoma (BAC) is a subtype of adenocarcinoma of the lung with uniq...
The majority of patients with non-small cell lung cancer (NSCLC) present with advanced stage at diag...
OBJECTIVE: This study aims to assess the international practice of management of bronchial carcinoi...
Objective: Yo evaluate methods of diagnosis and treatment, and the long term survival of patients tr...
International audienceBACKGROUND: Patients with a previous history of cancer of the upper respirator...
肺癌在全球范围内呈上升状态,仅2005年在美国新发病者就有172000例之多.非小细胞肺癌(non-small cell lung cancer,NSCLC)占肺癌的80.0%以上.其中细支气管肺泡癌...
Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the pati...
Lung cancer is the most devastating, yet preventable, cause of premature cancer mortality and morbid...
According to the number of deaths lung cancer is the leading cancer type, and non-small cell lung ca...
Copyright © 2013 Xiaofei Wang, Baohui Han. This is an open access article distributed under the Crea...
Surgery, chemotherapy, radiotherapy and "biological" treatment are differently used in the treatment...